| [1] |
Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden:Globocan 2000[J]. Int J Cancer, 2001, 94(2): 153-6.
|
| [2] |
Tanaka Y, Sawada S, Murata T. Relationship between lymph node metastases and prognosis in patients irradiated postoperatively for carcinoma of the uterine cervix[J]. Acta Radiol Oncol, 1984, 23 (6): 455-9.
|
| [3] |
Downey GO, Potish RA, Adcock LL, et al. Pretreatment surgical staging in cervical carcinoma:therapeutic efficacy of pelvic lymph node resection[J]. Am J Obster Gynecol, 1989, 160(5 Pt 1): 10 55-61.
|
| [4] |
Potish RA, Twiggs LB, Okagaki T, et al. Therapeutic implications of the natural history of advanced cervical cancer as defined by pretreatment surgical staging [J].Cancer, 1985, 56(4): 956-60.
|
| [5] |
Chou HH, Chang HP, Lai CH, et al. (18)F-FDG PET in Stage 1B/ IIB cervical adenocarcinoma/ adenosquamous carcinoma [J]. Eur J Nucl Med Mol Imaging, 2010, 37(4): 728-35.
|
| [6] |
Grigsby PW. PET/CT imaging to guide cervical cancer therapy[J]. Future Oncol, 2009, 5(7): 953-8.
|
| [7] |
Dolezelova H, Slampa P, Ondrova B, et al. The impact of PET with 18F-FDG in radio therapy treatment planning and in the prediction inpatient swith cervix carcinoma: results of pilot study[J]. Neoplasma, 2008, 55(5): 437-41.
|
| [8] |
Leeflang MM, Deeks JJ, Gatsonis C, et al. Systematic reviews of diagnostic test accuracy[J]. Ann Intern Med, 2008, 149(12): 88 9-97.
|
| [9] |
Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews[J]. BMC Med Res Methodol, 2003, 3: 25.
|
| [10] |
Rose PG, Adler LP, Rodriguez M, et al. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study[J]. J Clin Oncol, 1999, 17(1): 41-5.
|
| [11] |
Narayan K, Hicks RJ, Jobling T, et al. A comparison of MRI and PET scanning in surgically staged loco‐regionally advanced cervical cancer: Potential impact on treatment[J]. Int J Gynecol Cancer, 2001, 11(4): 263-71.
|
| [12] |
Reinhardt MJ, Ehritt-Braun C, Vogelgesang D, et al. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET[J]. Radiology, 2001, 218(3): 776-82.
|
| [13] |
Yeh LS, Hung YC, Shen YY, et al. Detecting para-aortic lymph nodal metastasis by positron emission tomography of 18 F-fluorodeoxyglucose in advanced cervical cancer with negative magnetic resonance imaging findings[J]. Oncol Rep, 20 02, 9(6): 1289-92.
|
| [14] |
Belhocine T, Thille A, Fridman V, et al. Contribution of wholebody 18 FDG PET imaging in the management of cervical cancer[J]. Gynecol Oncol, 2002, 87(1): 90-7.
|
| [15] |
Ryu SY, Kim MH, Choi SC, et al. Detection of early recurrence with 18F-FDG PET in patients with cervical cancer[J]. J Nucl Med, 2003, 44(3): 347-52.
|
| [16] |
Havrilesky LJ, Wong TZ, Secord AA, et al. The role of PET scanning in the detection of recurrent cervical cancer[J]. Gynecol Oncol, 2003, 90(1): 186-90.
|
| [17] |
Li n WC, Hu n g YC, Ye h LS , e t a l . Us e f u l n e s s o f (18) F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings[J].Gynecol Oncol, 20 03, 89(1): 73-6.
|
| [18] |
Lv SM. Clinical value of positron emission tomography and computed tomography (PET/CT) in the monitoring gynecologic malignant tumors[D]. Shandong University, 2005. [吕世明. 正电 子发射体层显像 (PET/CT) 检测妇科恶性肿瘤的临床价值[D]. 山东大学, 2005.]
|
| [19] |
Park W, Park YJ, Huh SJ, et al. The usefulness of MRI and PET imaging for the detection of parametrial involvement and lymph node metastasis in patients with cervical cancer[J]. Jpn J Clin Oncol, 2005, 35(5): 260-4.
|
| [20] |
Roh JW, Seo SS, Lee S, et al. Role of positron emission tomography in pretreatment lymph node staging of uterine cervical cancer: a prospective surgicopathologic correlation study[J]. Eur J Cancer, 2005, 41(14): 2086-92.
|
| [21] |
Choi HJ, Roh JW, Seo SS, et al. Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/ computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study[J]. Cancer, 2006, 106(4): 914-22.
|
| [22] |
Sironi S, Buda A, Picchio M, et al. Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT[J]. Radiology, 2006, 238(1): 272-9.
|
| [23] |
Chung HH, Jo H, Kang WJ, et al. Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence[J]. Gynecol Oncol, 2007, 104(3): 529-34.
|
| [24] |
Loft A, Berthelsen AK, Roed H, et al. The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study[J]. Gynecol Oncol, 2007, 106(1): 29-34.
|
| [25] |
Yildirim Y, Sehirali S, Avci ME, et al. Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings[J]. Gynecol Oncol, 2008, 108(1): 154-9.
|
| [26] |
Lu BY, Che WY, Yao SZ. Role of 18F-FDG PET/CT in diagnosing idiopathy and detecting lymph node metastasis in pelves of cervical cancer[J]. Yi Xue Ying Xiang Xue Za Zhi, 2008, 18(9): 10 52-4.[卢宝彦, 车文颖, 姚树展, 等. PET/CT显像在宫颈癌原 发灶诊断及盆腔淋巴结分期的价值[J]. 医学影像学杂志, 2008, 18 (9): 1052-4.]
|
| [27] |
Kim SK, Choi HJ, Park SY, et al. Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients[J]. Eur J Cancer, 2009, 45 (12): 2103-9.
|
| [28] |
Kitajima K, Murakami K, Yamasaki E, et al. Accuracy of integrated FDG-PET/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer[J].Eur Radiol, 2009, 19(6): 1529-36.
|
| [29] |
Chung HH, Park NH, Kim JW, et al. Role of integrated PET-CT in pelvic lymph node staging of cervical cancer before radical hysterectomy[J]. Gynecol Obstet Invest, 2009, 67(1): 61-6.
|
| [30] |
Chung HH, Kang KW, Cho JY, et al. Role of magnetic resonance imaging and positron emission tomography/computed tomography in preoperative lymph node detection of uterine cervical cancer[J]. Am J Obstet Gynecol, 2010, 203(2): 156.e1-5.
|
| [31] |
Sandvik RM, Jensen PT, Hendel HW, et al. Positron emission tomography-computed tomography has a clinical impact for patients with cervical cancer[J]. Dan Med Bull, 2011, 58(3): A4240.
|
| [32] |
Leblanc E, Gauthier H, Querleu D, et al. Accuracy of 18-fluoro- 2- deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma[J]. Ann Surg Oncol, 2011, 18(8): 2302-9.
|
| [33] |
Signorelli M, Guerra L, Montanelli L, et al. Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease?[J]. Gynecol Oncol, 2011, 123(2): 23 6-40.
|
| [34] |
Crivellaro C, Signorelli M, Guerra L, et al. 18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer[J]. Gynecol Oncol, 2012, 127(1): 131-5.
|
| [35] |
Chen HY, Wang DB, Li YN. Diagnostic value of PET-CT in detection of lymph node metastasis in early-stage cervical carcinoma[J]. Zhongguo Yi Ke Da Xue Xue Bao, 2013, 42(4): 35 1-4.[陈英汉, 王丹波, 李雅男, 等. PET-CT在检测早期子宫 颈癌淋巴结转移中的诊断价值[J]. 中国医科大学学报, 2013, 42 (4): 351-4.]
|
| [36] |
Coleman RL, Whitten CW, O'Boyle J, et al. Unexplained decrease in measured oxygen saturation by pulse oximetry following injection of Lymphazurin 1% (isosulfan blue) during a lymphatic mapping procedure[J]. J Surg Oncol, 1999, 70(2): 126-9.
|
下载:
